Zarazuela Zolkipli-cunningham | Faculty | About Us | Perelman School of Medicine | Perelman School of Medicine at the University of Pennsylvania

About Us
Our Faculty
Zarazuela Zolkipli-cunningham

Zarazuela Zolkipli-Cunningham, MBChB, MRCP

Assistant Professor of Pediatrics (Human Genetics) at the Children's Hospital of Philadelphia

Attending Physician, Mitochondrial Medicine Frontier Program, Division of Human Genetics, Children's Hospital of Philadelphia

Clinical Research Director, Mitochondrial Medicine Frontier Program, Division of Human Genetics, Children's Hospital of Philadelphia

Department: Pediatrics

Contact information

12th Floor, The Hub Building,
Children's Hospital of Philadelphia
3501 Civic Center Boulevard
Philadelphia, PA 19104

Office: 2674264961

Publications

Search PubMed for articles

Education:
MBChB
Edinburgh University Medical School, Scotland, UK, 1996.
MRCPCH
Royal College of Physicians, Edinburgh, Scotland, 1999.

Permanent link

> Perelman School of Medicine > Faculty > Details

Description of Clinical Expertise

Mitochondrial Myopathy diagnosis and management
Percutaneous Muscle Needle Biopsy
Mitochondrial Disease
Neuromuscular

Description of Research Expertise

Mitochondrial Myopathy outcome measures
Mitochondrial Myopathy exercise testing
Mitochondrial Myopathy clinical trials
Neuromuscular
Myopathy
Mitochondria
Exercise
Spinal Muscular Atrophy
Nanosensor
Muscle Oxygen
Leigh syndrome
Longitudinal Studies

Selected Publications

Jing Wang, James Peterson, Joaquim Diego Santos, Ada JS Chan, Maria Alejandra Diaz-Miranda, Imon Rahaman, Jean Flickinger, Amy Goldstein, Emily Bogush, Elizabeth M. McCormick, Colleen C. Muraresku, Vernon E. Anderson, Matthew Dulik, Douglas C. Wallace, Rui Xiao, Marni J. Falk, Angela N. Viaene, Zarazuela Zolkipli-Cunningham.: Interpreting the clinical significance of multiple large-scale mitochondrial DNA deletions (MLSMD) in skeletal muscle tissue in the diagnostic evaluation of primary mitochondrial disease. Frontiers in Pharmacology(6), April 2025 Notes: https://doi.org/10.3389/fphar.2025.1507493.

Coratti G, Civitello M, Rohwer A, Albamonte E, Montes J, Glanzman AM, Pasternak A, De Sanctis R, Young SD, Duong T, Mizzoni I, Milev E, Sframeli M, Morando S, D'Amico A, Catteruccia M, Brolatti N, Pane M, Scoto M, Messina S, Hirano M, Zolkipli-Cunningham Z, Darras BT, Bertini E, Bruno C, Sansone VA, Salmin F, Day J, Baranello G, Pera MC, Muntoni F, Finkel RS, Mercuri E: Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb Module. Neuromuscular Disorders 44(104449), November 2024.

George-Sankoh I, MacMullen LE, Chinwalla AT, Taylor D, Ganetzky R, Stanley K, McCormick EM, Zolkipli-Cunningham Z, Falk, MJ: MMFP-Tableau: enabling precision mitochondrial medicine through integration, visualization, and analytics of clinical and research health system electronic data. Journal of the American Medical Informatics Association 7(4), November 2024.

Coratti G, Bovis F, Pera MC, Civitello M, Rohwer A, Salmin F, Glanzman AM, Montes J, Pasternak A, De Sanctis R, Young SD, Duong T, Mizzoni I, Milev E, Sframeli M, Morando S, Albamonte E, D’Amico A, Brolatti N, Pane M, Scoto M, Messina S, Escudero JE, De Waele L, Hirano M, Zolkipli-Cunningham Z, Darras BT, Bertini E, Osorio AN, Bruno C, Goemans N, Sansone VA, Day J, Baranello G, Muntoni F, Finkel R, Mercuri E : Long-term natural history in type II and III spinal muscular atrophy: a 4-year international study on the Hammersmith Functional Motor Scale – Expanded. European Journal of Neurology September 2024 Notes: Accepted September 2024.

Ham H, Jing H, Lamborn IT, Kober MM, Koval A, Berchiche YA, Anderson DA, Druey KM, Mandl JN, Isidor B, Ferreira CR, Freeman AF, Ganesan S, Karsak M, Mustillo PJ, Teo J, Zolkipli-Cunningham Z, Chatron N, Lecoquierre F, Oler FJ, Schmid JP, Kuhns DB, Xu X, Hauck F, Al-Herz W, Wagner M, Terhal P, Muurinen M, Barlogis V, Cruz P, Danielson J, Stewart H, Loid P, Rading S, Keren B, Pfund R, Zarember KA, Vill K, Potocki L, Olivier KN, Lesca G, Faivre L, Wong M, Puel A, Chou J, Tusseau M, Moutsopoulos NM, Matthews HF, Simons C, Taft RJ, Soldatos A, Masle-Farquhar E, Pittaluga S, Brink R, Fink DL, Kong HH, Kabat J, Kim WS, Bierhals T, Meguro K, Hsu AP, Gu J, Stoddard J, Banos-Pinero B, Slack M, Trivellin G, Mazel B, Soomann M, Li S, Watts VJ, Stratakis CA, Rodriguez-Quevedo MF, Bruel A, Lipsanen-Nyman M, Saultier P, Jain R, Lehalle D, Torres D, Sullivan KE, Barbarot S, Neu A, Duffourd Y, Similuk M, McWalter K, Blanc P, Bézieau S, Jin T, Geha RG, Casanova JL, Makitie OM, Kubisch C, Edery P, Christodoulou J, Germain RN, Goodnow CC, Sakmar TP, Billadeau DD, Küry S, Katanaev VL, Zhang Y, Lenardo MJ, Su HC: G-proteins can promote T cell responses through a non-canonical cAMP-independent pathway. Science 20(385), September 2024 Notes: doi: 10.1126/science.add8947.

McGrattan K, Cerchiari A, Conway E, Berti B, Finkel R, Muntoni F, Mercuri E; iSMAC working group: : Fanelli, L, Coratti G, Sansone V, Albamonte E, Trucco F, Latini S, Bertini E, d’Amico A, Doglio L, Stimpson G, Baranello G, Scoto M, Rohwer A, Edel L, Lofra RM, Bettolo CM, Young SD, Day J, Duong T, Darras B, Pasternak A, Montes J, Rodiguez- Torres R, Chriboga C, Hirano M, Civitello M, Zolkipli-Cunningham Z, Brandsema J, Mayer H, Glanzmann A, Karagiannis J, Baldinetti F, Khader L, Costa P, Lovato I, Rastelleti I. : Bulbar function in spinal muscular atrophy (SMA): State of art and new challenges. 21st July 2023, Rome, Italy. Neuromuscul Disord 38: 44-50, May 2024 Notes: doi: 10.1016/j.nmd.2024.02.003. Epub 2024 Mar 8.

Trucco F, Ridout D, Weststrate H, Scoto M, Rohwer A, Coratti A, Main M, Mayhew A, Montes J, Sanctis RD, Pane M, Pera MC, Sansone VA, Albamonte E, D’Amico A, Bruno C, Messina S, Childs AM, Willis T, Ong M, Servais L, Majumdar A, Hughes I, Marini-Bettolo C, Parasuraman D, Gowda V, Baranello G, Bertini E, De Vivo DC, Darras B, Day JD, Mayer OH, Zolkipli-Cunningham Z, Finkel RS, Mercuri E, Muntoni F,on behalf of the iSMAC group: Therapeutic Role of Nusinersen on Respiratory Progression in Pediatric Patients with Spinal Muscular Atrophy Type 2 and Non-Ambulant Type 3. Neurology Clinical Practice 14(3), May 2024 Notes: doi: 10.1212/CPJ.0000000000200298.

Harding ER *, Kanner CA, Pasternak A, Glanzman AM, Young SD, Rao AK, McDermott MP, Zolkipli-Cunningham A, Day JW, Finkel RS, Darras BT,De Vivo DC, Montes J : Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint Hypermobility. Journal of Clinical Medicine April 2024.

Wolfe A, Stimpson G, Ramsey D, Coratti G, Young SD, Mayhew A, Pane M, Rohwer A, Lofra RM, Duong T, O'Reilly E, Milev E, Civitello M, Sansone VA, D'Amico A, Bertini E, Messina S, Bruno C, Albamonte E, Mazzone E, Main M, Montes J, Glanzman AM, Zolkipli-Cunningham Z, Pasternak A, Marini-Bettolo C, Day JW, Darras BT, De Vivo DC, Baranello G, Scoto M, Finkel RS, Mercuri E, Muntoni F; international SMA consortium (iSMAc): Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3. Journal of Neuromuscular Disease February 2024 Notes: doi: 10.3233/JND-230211.

MacMullen L, George-Sankoh I, Stanley K, McCormick EM, Muraresku CC, Goldstein A, Zolkipli-Cunningham Z, Falk MJ: Bridging the Clinical-Research Gap: Harnessing an electronic data capture, integration, and visualization platform to systematically assess prospective patient-reported outcomes in mitochondrial medicine   Molecular Genetics and Metabolism February 2024 Notes: Accepted February 2024.